L. Solán

发表

ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide

I. Buño, J. Anguita, J. Díez-Martín, 2019, Front. Immunol..

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

P. Galan, J. González-Porras, M. Álvarez‐Román, 2014, American journal of hematology.

Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation.

I. Buño, J. Anguita, J. Díez-Martín, 2019, Blood advances.

Allogeneic stem cell transplantation in HIV-1 infected patients with high-risk hematological disorders.

J. Anguita, J. Sanz, J. Díez-Martín, 2019, AIDS.

Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant

J. Anguita, A. Balas, J. Vicario, 2021, Frontiers in Immunology.

Cytokine Release Syndrome after Allogeneic Stem Cell Transplantation with Post Transplant Cyclophosphamide

J. Anguita, J. Díez-Martín, C. Martínez-Laperche, 2018, Blood.

Cytokine release syndrome after allogeneic stem cell transplantation with posttransplant cyclophosphamide

J. Anguita, J. Díez-Martín, M. Kwon, 2020, Hematological oncology.

Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms

I. Buño, P. Catalán, J. Triviño, 2022, Annals of Hematology.

Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide

I. Buño, J. Anguita, J. Díez-Martín, 2021, Frontiers in Immunology.

Hemophagocytic Lymphohistiocytosis Secondary to Hodgkin’s Lymphoma with Isolated Bone Marrow Involvement in a Newly Diagnosed HIV Patient

A. López-García, M. Rodríguez-Pinilla, J. Caballero, 2023, Medicina.

Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy

J. Anguita, A. Balas, J. Vicario, 2023, Frontiers in Immunology.